| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 141 | SWEETENER COMPOSITIONS | US15687355 | 2017-08-25 | US20180070621A1 | 2018-03-15 | Dennis Wong; Horst Krupp |
| A sweetener composition comprising xylose, a sugar alcohol and brown seaweed extract in solid form, preferably powdered or crystalline form. The sugar alcohol is preferably an erythritol and the brown seaweed extract is preferably obtained from Laminaria japonica. The sweetener composition can further comprise one or a combination of additional vitamins, minerals, probiotic cultures, and other plant-based extracts. | ||||||
| 142 | COMPOSITIONS AND METHODS FOR PROMOTING GROWTH OF BENEFICIAL MICROBES TO TREAT OR PREVENT DISEASE OR PROLONG LIFE | US15499390 | 2017-04-27 | US20180000876A1 | 2018-01-04 | Mitsuko L. Yamamoto; Robert H. Schiestl; Ramune Reliene; James Borneman; Laura L Presley; Jonathan Braun |
| Inoculation of ATM-deficient mice with probiotic microorganisms, such as L. johnsonii, changed immune parameters, decreased a marker of DNA damage and increased the lifespan of the mice. Compositions and methods described herein are useful for the treatment and prevention of Ataxia telangiectasia and other cancer-prone disease, such as p53 deficiency-associated cancers. Compositions and methods of the present invention are also useful for treating and preventing radiation-induced toxicity to normal tissue in a subject being exposed to radiation, Compositions and methods of the invention can increase lifespans in a simple, non-invasive manner. | ||||||
| 143 | Probiotic and polyphenol against neurodegeneration | US14406980 | 2013-06-20 | US09801915B2 | 2017-10-31 | Rachid Bel-Rhlid; Jane Durga; Tina Kunz; Jeroen Antonius Johannes Schmitt |
| The present invention relates to a composition comprising the probiotic strain Lactobacillus johnsonii CNCM I-1225 in combination with a polyphenol for use in the treatment or prevention of a cognitive and/or neurodegenerative disorder, in particular Alzheimer's disease. | ||||||
| 144 | COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIZING ENTEROCOLITIS IN INFANTS AND YOUNG CHILDREN | US15036843 | 2014-11-14 | US20160296540A1 | 2016-10-13 | Per Torp Sangild |
| The invention discloses a composition comprising an oligosaccharide mixture, said oligosaccharide mixture comprising from 40 to 80 wt % of fucosylated oligosaccharide(s), from 10 to 50 wt % of N-acetylated oligosaccharide(s), from 5 to 40 wt % of sialylated oligosaccharide(s) and from 0 to 20 wt % of precursor(s) of human milk oligosaccharide, for use in preventing and/or in treating necrotizing enterocolitis in infants and young children. | ||||||
| 145 | Lactic acid bacterium for inhibiting production of gastric acid and gastrin | US13337544 | 2011-12-27 | US09243300B2 | 2016-01-26 | Yasuhiro Nakano; Yuji Aiba; Michihiko Kumagai; Fumiya Asukabe; Yasuhiro Koga |
| A method of reducing the acid concentration within gastric fluid, suppressing a tendency towards a strongly acidic pH within the gastric fluid, and inhibiting the production of gastrin involves the step of administering live or killed lactic acid bacterium (such as Lactobacillus johnsonii No. 1088) to a living subject. The invention also relates to a method of alleviating the side effects caused by continuous administration of a proton pump inhibitor by administering live or killed lactic acid bacterium to a living subject. | ||||||
| 146 | PROBIOTIC AND POLYPHENOL AGAINST NEURODEGENERATION | US14406980 | 2013-06-20 | US20150174177A1 | 2015-06-25 | Rachid Bel-Rhlid; Jane Durga; Tina Kunz; Jeroen Antonius Johannes Schmitt |
| The present invention relates to a composition comprising the probiotic strain Lactobacillus johnsonii CNCM I-1225 in combination with a polyphenol for use in the treatment or prevention of a cognitive and/or neurodegenerative disorder, in particular Alzheimer's disease. | ||||||
| 147 | EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS | US14541434 | 2014-11-14 | US20150072033A1 | 2015-03-12 | Annick Mercenier; Antoine Wermeille; Audrey Demont; Guenolee Prioult |
| The present invention generally relates to the field of pro biotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic microorganisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system. | ||||||
| 148 | Complete liquid nutrition for children at the age of 1-10 years comprising probiotics | US13319961 | 2010-05-11 | US08603492B2 | 2013-12-10 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition for children. In particular, the present invention relates to the nutritional compositions intended for children with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to children with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms. | ||||||
| 149 | BIFIDOBACTERIUM LONGUM NCC2705 (CNCM I-2618) AND IMMUNE DISORDERS | US13901176 | 2013-05-23 | US20130260440A1 | 2013-10-03 | Valerie Petit; Clara Garcia-Rodenas; Monique Julita; Guenolee Prioult; Annick Mercenier; Sophie Nutten |
| The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of B. longum NCC2705 (deposit number CNCM 1-2618) for use in the treatment or prevention of disorders related to the immune system including infections. | ||||||
| 150 | GROWING UP MILKS CONTAINING PROBIOTIC MICRO-ORGANISMS | US13319477 | 2010-05-11 | US20120269789A1 | 2012-10-25 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition for infants and young children. In particular, the present invention relates to growing-up milks comprising probiotic micro-organisms to be administered to infants and young children older than 10 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 151 | ORAL NUTRITIONAL SUPPLEMENT FOR CHILDREN COMPRISING PROBIOTICS | US13319943 | 2010-05-11 | US20120189598A1 | 2012-07-26 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition for children. In particular, the present invention relates to the field of oral supplements. One embodiment of the present invention relates to the field of oral supplements comprising probiotics and/or bioactive non-replicating probiotics, for example heat treated probiotics. | ||||||
| 152 | NUTRITIONALLY BALANCED STANDARD TUBE FEEDING FORMULA CONTAINING PROBIOTICS | US13319947 | 2010-05-11 | US20120141444A1 | 2012-06-07 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding formulas for complete nutrition comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | ||||||
| 153 | INFANT FEEDING FORMULAS COMPRISING PROBIOTIC MICRO-ORGANISMS | US13319627 | 2010-05-11 | US20120128726A1 | 2012-05-24 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of infant nutrition. In particular, the present invention relates to infant feeding formulas comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 154 | BREAKFAST CEREALS CONTAINING PROBIOTIC MICRO ORGANISMS | US13319965 | 2010-05-11 | US20120121685A1 | 2012-05-17 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition. In particular, the present invention relates to a breakfast cereal composition comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 155 | SPECIALIZED NUTRITIONAL FORMULA FOR ADULT PATIENTS WITH GASTROINTESTINAL INTOLERANCE CONTAINING PROBIOTICS | US13319949 | 2010-05-11 | US20120121563A1 | 2012-05-17 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition for adults. In particular, the present invention relates to the nutritional compositions intended for adults with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to adults with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms. | ||||||
| 156 | METHOD FOR PRODUCING A FERMENTED MILK PRODUCT | US13381195 | 2010-06-30 | US20120107450A1 | 2012-05-03 | Ditte Marie Folkenberg; Gunnar Oregaard; Mads Bennedsen; Lone Poulsen |
| The present invention relates to a method for producing a fermented milk product with enhanced gel stiffness, wherein a polysaccharide producing Lactobacillus strain is used. | ||||||
| 157 | INFANT AND YOUNG CHILDREN FEEDING FORMULA COMPRISING PROBIOTICS FOR INFANTS AND YOUNG CHILDREN | US13319638 | 2010-05-11 | US20120064051A1 | 2012-03-15 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of infant and young children nutrition. In particular, the present invention relates to infant and young children feeding formulas comprising probiotic micro-organisms to be administered to infants and young children older than 6 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 158 | Methods of preventing peritonitis by administering lactic acid bacterium | US10247841 | 2002-09-20 | US07217414B2 | 2007-05-15 | Eduardo Schiffrin; Carlos Guarner; German Soriano |
| The present invention relates to the use of lactic acid bacteria capable of adhering to the mucosa of the intestine and especially colonizing it for the prevention of peritonitis. In particular, the present invention relates to the use of such lactic acid bacteria for the prevention of peritonitis caused by cirrhosis of the liver. Specifically, the present invention relates to a method for preventing peritonitis in a patient in need of such prevention. This method includes administering to the patient a lactic acid bacterium that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier. The invention also relates to a peritonitis preventing composition of a lactic acid bacterium that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier. The carrier is preferably a food or pharmaceutical composition. | ||||||
| 159 | Lactic acid bateria capable of reducing an individual's tendency to develop allergic reactions | US10362249 | 2003-09-08 | US20040071714A1 | 2004-04-15 | Jacques Edouard Germond; Blaise Corthesy; Beat Molltet; Rodolphe Fritsche |
| The present invention pertains to novel strains of lactic acid bacteria that are capable to reduce an individual's tendency to mount allergic reactions. In particular, the present invention relates to the generation of lactic acid bacteria strains that express proteins including tolerogenic peptides and the use thereof in reducing an individual's tendency to mount allergic reactions. The invention also pertains to food or pharmaceutical compositions containing said micro-organisms or active fractions thereof. | ||||||
| 160 | ABSORPTION OF MINERALS BY INTESTINAL CELLS | US09445796 | 2000-03-13 | US20020127211A1 | 2002-09-12 | DOMINIQUE BRASSART; ELISABETH VEY |
| A method for increasing or facilitating the absorption of minerals from the diet. A nutritional composition which contains lactobacilli is enterally administered to a mammal. The nutritional composition is suitable for the treatment or prophylaxis of sutjects having mineral deficiencies, or to compensate for physiological deficiencies due to a diet low in minerals, or to satisfy major physiological requirements for minerals in young children. pregnant women, women who are breastieeding, and the elderly. | ||||||
QQ群二维码
意见反馈
意见反馈